AIHealthcare

Riverain Technologies is a privately held clinical AI and medical-imaging software company focused on cardiothoracic imaging. Its ClearRead product suite uses AI and image-suppression technology to help radiologists identify and characterize findings in chest X-rays and CT scans, including lung disease and lung nodules. The company states that its products are FDA-cleared and can be deployed in clinical or cloud environments. Riverain reported more than 400 customer locations globally; in a February 2024 announcement, it reported 286% growth in 2023 and 30 new customers, with deployments including Veterans Administration and U.S. Department of Defense medical facilities. Its stated market position is as a specialist in AI-enabled chest imaging and early cardiothoracic disease detection rather than a general-purpose healthcare-AI vendor.